Yubo International Biotech Limited
Financial ratios & Valuation

Historical Multiples (2013 – 2022)

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 TTM Median
Valuation Ratios
Price/Earnings ratio
-5.14-4.99-4.56-4.07-2.36-3.67-3.57-74.60-31.94-9.36-3.70-3.67
Price/Sales ratio
8.158.82N/AN/AN/AN/AN/A39.2239.58108.158.23N/A
Price/Book Value ratio
-0.58-0.52-0.46-0.42-0.38-0.34-0.3145.47-375.42-19.94-16.03-0.34
Price/Cash Flow ratio
-13.94-11.51-8.40-9.46-9.63-9.63-16.55525.21-48.24165.29423.94-9.63
Price/Free Cash Flow ratio
-13.94-11.51-8.40-9.46-9.63-9.63-16.5514.59K-31.06396.27-320.57-9.63
Price/Earnings Growth ratio
-0.22-1.74-0.48-0.34-0.030.09-0.420.78-0.260.40N/A-0.03
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
100%100%N/AN/AN/AN/AN/A91.55%65.94%50.48%65.85%N/A
Operating Profit Margin
-92.30%-91.66%N/AN/AN/AN/AN/A-52.57%-123.98%-1155.72%-222.47%N/A
Pretax Profit Margin
-158.46%-176.66%N/AN/AN/AN/AN/A-52.57%-123.95%-1155.50%-222.43%N/A
Net Profit Margin
-158.46%-176.66%N/AN/AN/AN/AN/A-52.57%-123.91%-1155.28%-222.43%N/A
Effective Tax Rate
N/AN/AN/AN/AN/AN/AN/A-0.00%0.02%0.01%N/AN/A
Return on Assets
-686.66%-963.63%-773.33%-928.57%-5600%-2880%-3700%-29.11%-33.61%-51.29%-76.61%-5600%
Return On Equity
11.36%10.47%10.28%10.33%16.32%9.49%8.89%-60.96%1175.33%213.09%406.96%16.32%
Return on Capital Employed
6.62%5.43%5.14%5.00%10.86%3.82%2.88%-60.96%-85.84%688.98%-380.34%3.82%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A0.26N/A
Quick Ratio
0.010.010.010.010.000.000.001.440.320.160.140.00
Cash ratio
0.010.000.010.000.000.000.001.080.000.000.030.00
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/AN/A116.45164.121.20K94.86N/A
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/AN/A214.46141.532.27K108.92N/A
Operating Cycle
N/AN/AN/AN/AN/AN/AN/A330.92305.653.48K132.31N/A
Days of Payables Outstanding
N/AN/AN/AN/AN/AN/AN/A323.16237.603.88K570.74N/A
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/AN/A7.7568.05-400.64-449.02N/A
Debt Ratios
Debt Ratio
31.7351.6346.258.28233.75230.2321.250.120.580.331.17230.2
Debt Equity Ratio
-0.52-0.56-0.61-0.64-0.68-0.75-0.770.26-20.53-1.39-6.65-0.75
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/AN/A1.07-2.231.87N/A
Total Debt to Capitalization
-1.10-1.27-1.59-1.84-2.13-3.15-3.390.211.053.511.42-2.13
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-4.23KN/A
Cash Flow to Debt Ratio
-0.07-0.08-0.09-0.06-0.05-0.04-0.020.32-0.370.080.01-0.05
Company Equity Multiplier
-0.01-0.01-0.01-0.01-0.00-0.00-0.002.09-34.96-4.15-5.65-0.00
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-0.58-0.76N/AN/AN/AN/AN/A0.07-0.820.650.01N/A
Free Cash Flow / Operating Cash Flow Ratio
11111110.031.550.41-1.321
Cash Flow Coverage Ratio
-0.07-0.08-0.09-0.06-0.05-0.04-0.020.32-0.370.080.01-0.05
Short Term Coverage Ratio
-0.07-0.08-0.09-0.06-0.05-0.04-0.020.32-1.330.170.03-0.05
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A